Professional Documents
Culture Documents
Neurological:
LOC: 1 Orientation: UTA- speaks SpanishOrdered Sedation: none
Opens eyes: yes GCS: 15 (I witnessed him speak with a physician who speaks Spanish)
Pupils: PERRLA- sluggish Speech: UTA Tongue: Moist Face Symmetry:
symmetrical
Cardiovascular:
Rhythm: NSR Pulse: Regular Heart Sounds: Normal S1 and S2
JVD: none Cap Refill: <3 secs Pacemaker: none
CVP: no PCWP: no Cyanosis location: none
Peripheral Vascular:
Pulses: palp Radial: R 2+ L 3+ Pedal: R 2+ L 2+ Post Tibial: R: 2+ L 2+
Edema: Yes; generalized; 2+
Respiratory:
Breath Sounds: ronchi and crackles heard throughout; diminished breath sounds
Sputum: white and frothy
Chest Tubes: none Cough: yes; non-productive
GI:
Diet: tube feed; semi-elemental PEG tube Abdomen: soft, non-distended
Bowel Sounds: normo-active X4 Stool: none- last stool yesterday
Ostomy: None FMS: None Color/Characteristic: UTA
GU:
Urine: yellow Clarity: clear Catheter: external Genital Irritation: no
Skin:
Temp: warm Color: appropriate Turgor: good
Mucous Membranes: moist Incisions: none Wounds: face and legs d/t proning
Musculoskeletal:
UE Movment: none Strength: weak Sensation: full
LE Movement: none Strength: weak Sensation: full
Continuous IV Drips:
Dextrose 5% 100 ml/hr L arm peripheral
24 hr. Intake: 1638
24 hr. Output: 1250
Cumulative Fluid Balance: +388
Pain/Pain Management: no objective signs of pain
Normal Day prior Day of care Reason for abdormal
Na 132-146
K 3.5-5 4.0 4.2
Cl 98-107 99 99
CO2 34-45 43.2 43
Glucose 70-100 175 159 Diabetes
BUN 8-23 50 58 CKD
Cr 0.7-1.2 0.4 0.4 CKD
Calcium 8.6-10.2 8.7 8.8
Albumin 3.5-5.2 2.6 No value Poor nutrition, poss. Liver
dysfn
Total protein 6.4-8.3 No value No value
ALP 40-129 No value 133 Possible liver dysfn, biliary
dsyfn
ALT 0-32 30 30
AST 0-31 28 28
Total Bilirubin 0-1.2 .6 .7
Chest xray: pneumopericardium present and subcutaneous emphysema in the neck. Bilateral airspace
disease stable.
Other pertinent tests: US retroperitoneal d/t Stage 2 CKD. No evidence of hydronephrosis, perinephric
collections, renal calculi or solid renal masses.
Treatments:
Mouthcare and suctioning Q2H PRN for prophylaxis against ventilator associated pneumonia
A/C: rate 16, TV 320, FiO2 .5, PEEP 8
DVT prevention: enoxaparin subQ
Bedrest, side rails up X4
Foley care
Assess IVs Q2H
Pathophysiology: Acute hypercapnic respiratory failure is usually caused by defects in the central nervous
system, impairment of neuromuscular transmission, mechanical defect of the ribcage and fatigue of
the respiratory muscles. Fluid builds up in the air sacs in the lungs. The lungs can’t release oxygen to the
blood and organs aren’t being perfused. Carbon dioxide cannot be removed.
Nursing care: Oxygen therapy, ipratropium-albuterol given. Patient will be closely observed for potential
deterioration. Respiratory assessment occurring on a frequent/continual basis. Monitoring involves
continual pulse oximetry and regular peak expiratory flow rate measurement, and also basic respiratory
rate monitoring and general assessment.
Medications Allergies: no known
Brand Name Tylenol Lipitor Bumex Lovenox
Generic Name Acetaminophen Atorvastatin Bumetanide Enoxaparin
Dose 650 mg Q6H PRN 80 mg nightly 1 mg Q8H 70 mg BID
Route PEG PEG IV SubQ
Problem 8: Anxiety
- RR very high
- Prescribed hydroxyzine
- On vent without a
Problem 2: Ineffective airway sedative
clearance Problem 1: Impaired Gas - ICU with a windowless
- Rochi and Rales Exchange room
- Nonproductive cough - ABGs: pH 7.44 PCO2 - Been in ICU for over a
- Frothy sputum on 43.2 PO2 81.2 HCO3 29.2 month
suctioning - Sub Q emphysema - Impaired verbal
- Diminished breath sounds - Trach placement communication: speaks
- Ipatropium-albuterol - RR in the 30s spanish
inhalation - FiO2 50%
Problem 3: Ineffective
breathing pattern Problem 7: Impaired skin
Reason for Needing Health Care integrity
- RR in ranging Acute Respiratory Failure, CKD,
from 26-36 - Prone positioning
Hypokalemia due to previous
- Diminished lung 65 year old male, DNR-CCA
sounds COVID-19
- Use of accessory diagnosis
Key Assessments: - Wounds on all
muscles - VS with focus on Respiratory extremities and face
- Set to go to Select Allergies: no known
but won’t take
him until his RR is
under control
Predicted Behavioral Outcome Objective (s): The pt will have ABGs within normal limits and
will have an SaO2> 90% on day of care
1. Monitor RR, depth and effort 1. Pt will have normal RR without use of
accessory muscles
2. Monitor ABGs 2. Pt will have normalized ABGs
3. Observe nail beds and skin 3.Pt will have cap refill < 3 secs and skin
for cyanosis will be appropriate for ethnicity
4. Monitor SaO2 continuously 4. Pt will have SaO2 > 90%
5. Place pt in semi-fowlers 5. Pt will have increased thoracic capacity
position
6. Administer ordered 6. Pt will improve ventilatory status
ipratropium-albuterol
Evaluation of outcomes objectives: The patient’s RR has not normalized; it is irregular and ranges from 26-36
and there is use of accessory muscles. ABGs are not normal, however, the patient did have a cap refill over
under 3 seconds and there is no sign of cyanosis. SaO2 is over 90%. Goal partially met; will continue to
monitor.
Predicted Behavioral Outcome Objective (s): The patient will have increased bilateral breath
sounds with productive cough and secretions becoming thinner and clearer or day of care.
Evaluation of outcomes objectives: The pt has ronchi and rales, and diminished breath sounds on both sides.
The secretions are frothy and white, and does not appear to be thinning. Suctioning is productive; but not a lot
of secretions are coming up. Bronchodilator administered as ordered; however, it does not seem to be working.
Pt turned Q2 hours, but not helping. Goal not met.
Predicted Behavioral Outcome Objective (s): Patient maintains an effective breathing pattern, as
evidenced by a relaxed breathing at normal rate and depth and absence of dyspnea on day of
care.
Evaluation of outcomes objectives: Pts RR has not normalized, and has rales and ronchi with diminished
breath sounds. Albumin is low, reducing respiratory strength. Although pt has no verbally communicated with
me, he seems restless alerting me to anxiety. SaO2 is within normal limits, and suctioning provides some
relief. Goal partially met.
Predicted Behavioral Outcome Objective (s): The patient will maintain NSR, vital signs within
normal limits, and a normal MAP on the day of care.
Predicted Behavioral Outcome Objective (s): The patient will have a balanced fluid intake and
output on the day of care.
Evaluation of outcomes objectives: The patient did not have a balanced I&O; cumulative fluid balance was
+388. Pt does have some generalized edema in the dependent areas, however, HR and BP are within normal
limits. A diuretic was given, but the patient was still oliguric during the time I provided care. Goal not met.
Predicted Behavioral Outcome Objective (s): The patient’s will be able to perform ROM
exercises and increase strength on day of care.
Predicted Behavioral Outcome Objective (s): The patient will remain free from any further skin
breakdown and the wounds currently present will continue to heal on day of care.
Evaluation of outcomes objectives: Pts wounds are healing; they are dry and beginning to scab. They are small
and appear free from infection. The patient’s temp has remained within normal limits, skin is dry and has been
turned Q2 hours. Pressure reducing devices such as pillows and foam wedges were used. There is no evidence
of further breakdown. Goal has been met.
Predicted Behavioral Outcome Objective (s): The patient will reduce RR and report decreasing
levels of anxiety on day of care.